{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:21:46Z","timestamp":1764721306272,"version":"3.46.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ensci.2025.100583","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:12:34Z","timestamp":1756480354000},"page":"100583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of intravenous Levetiracetam as first-line treatment for neonatal clinical seizures: A single-center study (2021\u22122023)"],"prefix":"10.1016","volume":"41","author":[{"given":"Mojtaba","family":"Movahedinia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Reza","family":"Mirjalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges Abedi","family":"Ardekani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farimah","family":"Shamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ensci.2025.100583_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3345\/cep.2021.01361","article-title":"Neonatal seizures: diagnostic updates based on new definition and classification","volume":"65","author":"Kim","year":"2022","journal-title":"Clin Exp Pediatr [Internet]"},{"issue":"23","key":"10.1016\/j.ensci.2025.100583_bb0010","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1089\/neu.2014.3352","article-title":"Long-term consequences of traumatic brain injury: current status of potential mechanisms of injury and neurological outcomes","volume":"32","author":"Bramlett","year":"2015","journal-title":"J Neurotrauma [Internet]"},{"issue":"10","key":"10.1016\/j.ensci.2025.100583_bb0015","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00415-020-09926-w","article-title":"A review of seizures and epilepsy following traumatic brain injury","volume":"267","author":"Fordington","year":"2020","journal-title":"J Neurol [Internet]"},{"key":"10.1016\/j.ensci.2025.100583_bb0020","series-title":"Seizures in the Neonate: A Review of Etiologies and Outcomes","first-page":"48","volume":"85","author":"Pisani","year":"2021"},{"issue":"3","key":"10.1016\/j.ensci.2025.100583_bb0025","first-page":"1564","volume":"18","author":"Ziobro","year":"2021","journal-title":"Novel Ther. Neonatal Seizures"},{"issue":"2","key":"10.1016\/j.ensci.2025.100583_bb0030","first-page":"144","article-title":"Levetiracetam compared to phenobarbital as a first line therapy for neonatal seizures: an unexpected influence of benzodiazepines on seizure response","volume":"26","author":"Wagner","year":"2021","journal-title":"J Pediatr Pharmacol Ther JPPT Off J PPAG [Internet]"},{"issue":"4","key":"10.1016\/j.ensci.2025.100583_bb0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/09727531231185991","article-title":"Recent Progress in the development of new antiepileptic drugs with novel targets","volume":"30","author":"Belete","year":"2023","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.ensci.2025.100583_bb0040","series-title":"Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis. Vol. 12, Frontiers in neurology. Switzerland","first-page":"747745","author":"Qiao","year":"2021"},{"issue":"3","key":"10.1016\/j.ensci.2025.100583_bb0045","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev [Internet]"},{"issue":"4","key":"10.1016\/j.ensci.2025.100583_bb0050","article-title":"Levetiracetam mechanisms of action: from molecules to systems","volume":"15","author":"Contreras-Garc\u00eda","year":"2022","journal-title":"Pharmaceuticals (Basel) [Internet]"},{"issue":"1","key":"10.1016\/j.ensci.2025.100583_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/jpn.JPN_66_19","article-title":"Intravenous Levetiracetam for treatment of seizures in term and preterm neonates","volume":"15","author":"Karao\u011flu","year":"2020","journal-title":"J Pediatr Neurosci [Internet]"},{"key":"10.1016\/j.ensci.2025.100583_bb0060","doi-asserted-by":"crossref","first-page":"1345969","DOI":"10.3389\/fped.2023.1345969","article-title":"Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials","volume":"11","author":"Yeung","year":"2023","journal-title":"Front Pediatr [Internet]"},{"issue":"4","key":"10.1016\/j.ensci.2025.100583_bb0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0883073810384263","article-title":"Levetiracetam for treatment of neonatal seizures","volume":"26","author":"Abend","year":"2011","journal-title":"J Child Neurol [Internet]"},{"issue":"6","key":"10.1016\/j.ensci.2025.100583_bb0070","article-title":"Levetiracetam versus phenobarbital for neonatal seizures: a randomized controlled trial","volume":"145","author":"Sharpe","year":"2020","journal-title":"Pediatr. Int."},{"issue":"11","key":"10.1016\/j.ensci.2025.100583_bb0075","first-page":"841","article-title":"Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures","volume":"33","author":"Maitre","year":"2013","journal-title":"J Perinatol Off J Calif Perinat Assoc [Internet]"},{"key":"10.1016\/j.ensci.2025.100583_bb0080","series-title":"Comparative Outcomes of Levetiracetam and Phenobarbital Usage in the Treatment of Neonatal Seizures: A Retrospective Analysis","first-page":"7","volume":"12","author":"Toptan","year":"2024"},{"key":"10.1016\/j.ensci.2025.100583_bb0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yebeh.2018.09.015","article-title":"A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy","volume":"88","author":"Rao","year":"2018","journal-title":"Epilepsy Behav [Internet]"},{"issue":"4","key":"10.1016\/j.ensci.2025.100583_bb0090","first-page":"320","article-title":"Effectiveness of Levetiracetam as a first-line anticonvulsant for neonatal seizures","volume":"24","author":"Kreimer","year":"2019","journal-title":"J Pediatr Pharmacol Ther JPPT Off J PPAG [Internet]."},{"key":"10.1016\/j.ensci.2025.100583_bb0095","series-title":"Medical Forum Monthly [Internet]","article-title":"Effectiveness of Levetiracetam as a first line anticonvulsant for neonatal seizures","author":"Khan","year":"2021"},{"issue":"2","key":"10.1016\/j.ensci.2025.100583_bb0100","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0883073816678102","article-title":"Levetiracetam for the treatment of seizures in neonatal hypoxic ischemic encephalopathy","volume":"32","author":"Venkatesan","year":"2017","journal-title":"J Child Neurol [Internet]"},{"issue":"4","key":"10.1016\/j.ensci.2025.100583_bb0105","first-page":"1270","article-title":"The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants","volume":"117","author":"Tekgul","year":"2006","journal-title":"Pediatr. Int."},{"issue":"2","key":"10.1016\/j.ensci.2025.100583_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/pr.2012.66","article-title":"Neonatal seizures and postneonatal epilepsy: a 7-y follow-up study","volume":"72","author":"Pisani","year":"2012","journal-title":"Pediatr Res [Internet]"},{"issue":"1","key":"10.1016\/j.ensci.2025.100583_bb0115","first-page":"3683548","article-title":"Short-term neurodevelopmental outcome in term neonates treated with phenobarbital versus Levetiracetam: a single-center experience","volume":"2019","author":"Falsaperla","year":"2019","journal-title":"Behav Neurol [Internet]"},{"issue":"1","key":"10.1016\/j.ensci.2025.100583_bb0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12098-023-04905-1","article-title":"Levetiracetam versus Phenobarbitone for Management of Neonatal Seizures: a systematic review and Meta-analysis","volume":"92","author":"Kumar","year":"2025","journal-title":"Indian J Pediatr [Internet]"},{"issue":"1","key":"10.1016\/j.ensci.2025.100583_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/jpn.JPN_172_16","article-title":"Levetiracetam in neonatal seizures as first-line treatment: a prospective study","volume":"12","author":"Falsaperla","year":"2017","journal-title":"J Pediatr Neurosci [Internet]."},{"issue":"Suppl. 5","key":"10.1016\/j.ensci.2025.100583_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2007.01285.x","article-title":"Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain","volume":"48","author":"Kim","year":"2007","journal-title":"Epilepsia [Internet]"},{"key":"10.1016\/j.ensci.2025.100583_bb0135","series-title":"Levetiracetam Induced Behavioral Abnormalities in a Patient with Seizure Disorder: A Diagnostic Challenge. Vol. 2020, Case reports in psychiatry. United States","first-page":"8883802","author":"Ogunsakin","year":"2020"}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650225000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650225000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:18:09Z","timestamp":1764721089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650225000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S2405650225000371"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2025.100583","relation":{},"ISSN":["2405-6502"],"issn-type":[{"type":"print","value":"2405-6502"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of intravenous Levetiracetam as first-line treatment for neonatal clinical seizures: A single-center study (2021\u22122023)","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2025.100583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100583"}}